Fabrice Romano trained as a D.V.M. (Doctor in Veterinary Medicine) and specialized in ophthalmology and microsurgery. He began his career in 1989, working in medical technology at Domilens Laboratories, a leader of intraocular implants in Europe (acquired by Bausch & Lomb). While there, Dr. Romano was responsible for new lines of implants and surgical equipment for cataract treatment.
Dr. Romano’s career took him to Biomatech (NAMSA), Multi Active (McCann Erickson HealthCare), Sofradim (COVIDIEN), and EDAP-TMS. His 20-plus years in the industry provided him with experience in a host of capacities, from R&D to Marketing to Business Development, finally leading him to found his first start-up – Medtech, EyeTechCare – in 2008.
“I am particularly pleased to have Mérieux-Developpement as one of our shareholders, first because of one of the most prestigious names in French medicine, second because it is backed by a Group that is a world leader in diagnostics and therefore synonymous with power, and finally because, beyond financial considerations, the team has great expertise in our field.”